Cardiovascular Research

APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study.

Authors: Astrid Suchy-Dicey|||Barbara Howard|||W T Longstreth|||Eric M Reiman|||Dedra Buchwald

Affiliations: + Expand

Abstract

The apolipoprotein E (APOE) ε4 allele confers higher risk of neurodegeneration and Alzheimer's disease (AD), but differs by race/ethnicity. We examined this association in American Indians.

---

Chemical List

Apolipoprotein E4|||Apolipoproteins E

---

Reference List

Cuyvers E, Sleegers K. Genetic variations underlying Alzheimer’s disease: evidence from genome-wide association studies and beyond. Lancet Neurol. 2016;15:857–868.|||Shen L, Jia J. An Overview of Genome-Wide Association Studies in Alzheimer’s Disease. Neurosci Bull. 2016;32:183–190.|||Mahoney-Sanchez L, Belaidi AA, Bush AI, Ayton S. The Complex Role of Apolipoprotein E in Alzheimer’s Disease: an Overview and Update. J Mol Neurosci. 2016;60:325–335.|||Yu JT, Tan L, Hardy J. Apolipoprotein E in Alzheimer’s disease: an update. Annu Rev Neurosci. 2014;37:79–100.|||Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, et al. Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020;11:667.|||Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996;334:752–758.|||Ghisays V, Goradia DD, Protas H, et al. Brain imaging measurements of fibrillar amyloid-beta burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE epsilon4 allele. Alzheimers Dement. 2020;16:598–609.|||Caselli RJ, Langlais BT, Dueck AC, Chen Y, Su Y, Locke DEC, et al. Neuropsychological decline up to 20 years before incident mild cognitive impairment. Alzheimers Dement. 2020;16:512–523.|||Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349–1356.|||Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279:751–755.|||Kwon OD, Khaleeq A, Chan W, Pavlik VN, Doody RS. Apolipoprotein E polymorphism and age at onset of Alzheimer’s disease in a quadriethnic sample. Dement Geriatr Cogn Disord. 2010;30:486–491.|||Morris JC, Schindler SE, McCue LM, Moulder KL, Benzinger TLS, Cruchaga C, et al. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease. JAMA Neurol. 2019.|||Rajabli F, Feliciano BE, Celis K, Hamilton-Nelson KL, Whitehead PL, Adams LD, et al. Ancestral origin of ApoE epsilon4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet. 2018;14:e1007791.|||Morris HR, Al-Sarraj S, Schwab C, Gwinn-Hardy K, Perez-Tur J, Wood NW, et al. A clinical and pathological study of motor neurone disease on Guam. Brain. 2001;124:2215–2222.|||Galasko D, Salmon D, Gamst A, Olichney J, Thal LJ, Silbert L, et al. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology. 2007;68:1772–1781.|||Henderson JN, Crook R, Crook J, Hardy J, Onstead L, Carson-Henderson L, et al. Apolipoprotein E4 and tau allele frequencies among Choctaw Indians. Neurosci Lett. 2002;324:77–79.|||Rosenberg RN, Richter RW, Risser RC, Taubman K, Prado-Farmer I, Ebalo E, et al. Genetic factors for the development of Alzheimer disease in the Cherokee Indian. Arch Neurol. 1996;53:997–1000.|||Kataoka S, Robbins DC, Cowan LD, Go O, Yeh JL, Devereux RB, et al. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. Arterioscler Thromb Vasc Biol. 1996;16:918–925.|||Lee ET, Welty TK, Fabsitz R, Cowan LD, Le NA, Oopik AJ, et al. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol. 1990;132:1141–1155.|||Suchy-Dicey AM, Shibata D, Best LG, Verney SP, Longstreth WT, Lee ET, et al. Cranial Magnetic Resonance Imaging in Elderly American Indians: design, Methods, and Implementation of the Cerebrovascular Disease and Its Consequences in American Indians Study. Neuroepidemiology. 2016;47:67–75.|||Cholerton B, Omidpanah A, Madhyastha TM, Grabowski TJ, Suchy-Dicey AM, Shibata DK, et al. Total Brain and Hippocampal Volumes and Cognition in Older American Indians: the Strong Heart Study. Alzheimer Dis Assoc Disord. 2017;31:94–100.|||Suchy-Dicey A, Shibata D, Cholerton B, Nelson L, Calhoun D, Ali T, et al. Cognitive Correlates of MRI-defined Cerebral Vascular Injury and Atrophy in Elderly American Indians: the Strong Heart Study. J Int Neuropsychol Soc. 2020;26:263–275.|||North KE, Goring HH, Cole SA, Diego VP, Almasy L, Laston S, et al. Linkage analysis of LDL cholesterol in American Indian populations: the Strong Heart Family Study. J Lipid Res. 2006;47:59–66.|||Suchy-Dicey AM, Shibata DK, Madhyastha TM, Grabowski TJ, Longstreth WT Jr, Buchwald DS. Findings of Vascular Brain Injury and Structural Loss from Cranial Magnetic Resonance Imaging in Elderly American Indians: the Strong Heart Study. Neuroepidemiology. 2017;48:39–47.|||Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage. 1999;9:179–194.|||Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage. 2011;56:907–922.|||Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Naturegenetics. 2012;44:552–561.|||Delis DC, Kramer JH, Kaplan E, Ober BA, California Verbal Learning Test (CVLT-II). 2 ed. US: the Psychological Corporation; 2000.|||Wechsler D. Wechsler Adult Intelligence Scale. 4th ed. 2008.|||Benton AL, Hansher K. Multilingual aphasia examination. 2nd ed. AJA Associates; 1976.|||Teng EL, Chang Chui H. The Modified Mini-Mental (3MS) Examination. Journal Clinical Psychiatry. 1987;48:314–318.|||Marioni RE, Campbell A, Scotland G, Hayward C, Porteous DJ, Deary IJ. Differential effects of the APOE e4 allele on different domains of cognitive ability across the life-course. Eur J Hum Genet. 2016;24:919–923.|||Weissberger GH, Nation DA, Nguyen CP, Bondi MW, Han SD. Meta-analysis of cognitive ability differences by apolipoprotein e genotype in young humans. Neurosci Biobehav Rev. 2018;94:49–58.|||Lyall DM, Celis-Morales C, Lyall LM, Graham C, Graham N, Mackay DF, et al. Assessing for interaction between APOE epsilon4, sex, and lifestyle on cognitive abilities. Neurology. 2019;92:e2691–e8.|||Batterham PJ, Bunce D, Cherbuin N, Christensen H. Apolipoprotein E epsilon4 and later-life decline in cognitive function and grip strength. Am J Geriatr Psychiatry. 2013;21:1010–1019.|||Ready RE, Baran B, Chaudhry M, Schatz K, Gordon J, Spencer RM. Apolipoprotein E-e4, processing speed, and white matter volume in a genetically enriched sample of midlife adults. Am J Alzheimers Dis Other Demen. 2011;26:463–468.|||McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer’s disease and vascular dementia. Neurosci Lett. 2010;483: 62–66.|||Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?. Ann Hum Genet. 1999;63:301–310.|||Shaw JT, Tate J, Kesting JB, Marczak M, Berkholz JR, Lovelock PK, et al. Apolipoprotein E polymorphism in indigenous Australians: allelic frequencies and relationship with dyslipidaemia. Med J Aust. 1999;170:161–164.|||Demarchi DA, Salzano FM, Altuna ME, Fiegenbaum M, Hill K, Hurtado AM, et al. APOE polymorphism distribution among Native Americans and related populations. Ann Hum Biol. 2005;32:351–365.|||Eisenberg DT, Kuzawa CW, Hayes MG. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol. 2010;143:100–111.|||Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RC, et al. A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol. 2011;68:1569–1579.|||Rajan KB, Barnes LL, Wilson RS, Weuve J, McAninch EA, Evans DA. Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample. J Am Geriatr Soc. 2019;67:734–740.|||Knopman DS, Mosley TH, Catellier DJ, Coker LH. Atherosclerosis Risk in Communities Study Brain MRIS. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement. 2009;5:207–214.|||Duara R, Loewenstein DA, Lizarraga G, Adjouadi M, Barker WW, Greig-Custo MT, et al. Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity. Neuroimage Clin. 2019;22:101800.|||Sapkota B, Subramanian A, Priamvada G, Finely H, Blackett PR, Aston CE, et al. Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population. J Diabetes Complications. 2015;29:1191–1197.|||Irie F, Masaki KH, Petrovitch H, Abbott RD, Ross GW, Taaffe DR, et al. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. Arch Gen Psychiatry. 2008;65:906–912.|||Haan MN, Mayeda ER. Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly. Curr Cardiovasc Risk Rep. 2010;4:361–368.|||Sawyer K, Sachs-Ericsson N, Preacher KJ, Blazer DG. Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults. Gerontology. 2009;55:32–40.|||Weuve J, Barnes LL, Mendes de Leon CF, Rajan KB, Beck T, Aggarwal NT, et al. Cognitive Aging in Black and White Americans: cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia. Epidemiology. 2018;29:151–159.|||Verney S, Suchy-Dicey A, Cholerton B, Calhoun D, Nelson L, Montine T, et al. The associations among sociocultural factors and neuropsychological functionings in older American Indians: the Strong Heart Study. Neuropsychology. 2019.